Newsby HottubFor agents

2minutemedicine.com

Durvalumab plus enfortumab vedotin was approved for perioperative treatment of muscle-invasive bladder cancer

Add to CRM by Hottub

Everyone in this article who could become a relationship. Add opens CRM by Hottub's form, filled in; nothing is saved until you press Add there.

  • 2 Minute MedicineReporter, 2minutemedicine.com
    Add
  • Reviewed Marc SucciReporter, 2minutemedicine.com
    Add
  • MD (Harvard Medical School)Reporter, 2minutemedicine.com
    Add
  • 2minutemedicine.comOutlet
    Add